SynthesisWorld journal of surgical oncology2020

The efficacy and safety of combined immune checkpoint inhibitors (nivolumab plus ipilimumab): a systematic review and meta-analysis.

Jingjie Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.